Evidence map›Paper›PMID 34522382›Full record

ArticleClinical case reports2021

Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases.

Noriko Fujiwara, Mayu Watanabe, Akihiro Katayama, Yohei Noda, Jun Eguchi, Hitomi Kataoka, Shunsuke Kagawa, Jun Wada

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Noriko FujiwaraDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Mayu WatanabeDepartment of Primary Care and Medical Education Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.ORCID https://orcid.org/0000-0003-4253-3465
Akihiro KatayamaDiabetes Center Okayama University Hospital Okayama Japan.ORCID https://orcid.org/0000-0002-9729-7343
Yohei NodaDepartment of Otolaryngology-Head and Neck Surgery Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Jun EguchiDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Hitomi KataokaDepartment of Primary Care and Medical Education Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Shunsuke KagawaMinimally Invasive Therapy Center Okayama University Hospital Okayama Japan.
Jun WadaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Okayama University · JPOkayama University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.

Indexed as

C‐peptidediabetes mellitusimmune checkpoint inhibitorinsulin secretion

Identifiers

PMID34522382
PMCPMC8424178
OpenAlexW3197859954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.